1. Home
  2. INZY vs TTSH Comparison

INZY vs TTSH Comparison

Compare INZY & TTSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INZY
  • TTSH
  • Stock Information
  • Founded
  • INZY 2015
  • TTSH 1985
  • Country
  • INZY United States
  • TTSH United States
  • Employees
  • INZY N/A
  • TTSH N/A
  • Industry
  • INZY Biotechnology: Pharmaceutical Preparations
  • TTSH Blank Checks
  • Sector
  • INZY Health Care
  • TTSH Finance
  • Exchange
  • INZY Nasdaq
  • TTSH Nasdaq
  • Market Cap
  • INZY 255.3M
  • TTSH 275.5M
  • IPO Year
  • INZY 2020
  • TTSH N/A
  • Fundamental
  • Price
  • INZY $3.99
  • TTSH $6.24
  • Analyst Decision
  • INZY Buy
  • TTSH
  • Analyst Count
  • INZY 9
  • TTSH 0
  • Target Price
  • INZY $15.22
  • TTSH N/A
  • AVG Volume (30 Days)
  • INZY 1.3M
  • TTSH 59.1K
  • Earning Date
  • INZY 08-05-2025
  • TTSH 08-07-2025
  • Dividend Yield
  • INZY N/A
  • TTSH N/A
  • EPS Growth
  • INZY N/A
  • TTSH N/A
  • EPS
  • INZY N/A
  • TTSH 0.01
  • Revenue
  • INZY N/A
  • TTSH $343,352,000.00
  • Revenue This Year
  • INZY N/A
  • TTSH N/A
  • Revenue Next Year
  • INZY N/A
  • TTSH N/A
  • P/E Ratio
  • INZY N/A
  • TTSH $342.71
  • Revenue Growth
  • INZY N/A
  • TTSH N/A
  • 52 Week Low
  • INZY $0.72
  • TTSH $4.62
  • 52 Week High
  • INZY $6.24
  • TTSH $7.75
  • Technical
  • Relative Strength Index (RSI)
  • INZY 83.59
  • TTSH 51.69
  • Support Level
  • INZY $3.94
  • TTSH $5.89
  • Resistance Level
  • INZY $3.97
  • TTSH $6.51
  • Average True Range (ATR)
  • INZY 0.01
  • TTSH 0.23
  • MACD
  • INZY -0.10
  • TTSH -0.03
  • Stochastic Oscillator
  • INZY 100.00
  • TTSH 42.65

About INZY Inozyme Pharma Inc.

Inozyme Pharma Inc is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting bone health and blood vessel function. The company is focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. Its product candidate, INZ-701, is a soluble, recombinant, genetically engineered fusion protein that is designed to correct a defect in a pathway involving ENPP1 and ABCC6 deficiencies.

About TTSH Tile Shop Holdings Inc.

Tile Shop Holdings Inc is a specialty retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the United States. It manufactures its setting and maintenance materials, such as thinset, grout, and sealers. The company's primary market is retail sales to consumers, contractors, designers and home builders. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, metal and luxury vinyl tile.

Share on Social Networks: